Advanced Analytics for Medical Device Quality

Slides:



Advertisements
Similar presentations
Roadmap for Sourcing Decision Review Board (DRB)
Advertisements

District Leadership Team Stakeholder Involvement in the District Strategic Plan! Session #4 April 12th, 2011.
E-OCVM (Version 2) Explained Episode 3 - CAATS II Final Dissemination Event Alistair Jackson EUROCONTROL Episode 3 Brussels, 13 & 14 Oct 2009.
The key steps in an annual cycle Produce the annual work programme Create an annual Internal Audit plan for approval by the Audit Committee, typically.
Strengthening the Medical Device Clinical Trial Enterprise
Revalidation and Code review update November 2014.
1 FDA Update - CDRH Markham C. Luke, MD PhD Deputy Director for Clinical Office of Device Evaluation, CDRH, FDA May 15, 2012 NORD Corporate Council.
Bree Collaborative Cardiology Report: Appropriateness of Percutaneous Cardiac Interventions (PCI) Bree Collaborative Meeting November 30, 2012.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
Sixth Annual Meeting March 12, :00am to 4:00pm Crowne Plaza National Airport Arlington, VA INTERMACS Annual Meeting March 2012.
CADTH Therapeutic Reviews
IS&T Project Management: Project Management 101 June, 2006.
ONC Policy and Program Update Health IT Policy Committee Meeting July 9, 2013 Jodi Daniel Director, Office of Policy and Planning, ONC 0.
Quality Improvement Prepeared By Dr: Manal Moussa.
Internal Auditing and Outsourcing
What is Business Analysis Planning & Monitoring?
Revenue Cycle Management Medical Technology Acquisition and Assessment Team Members: Joseph Dixon, Michael Morotti, Mari Pirie-St. Pierre, David Robbins.
Implementing a Calibration Management System Cory Otto Principal Metrology Engineer, Boston Scientific 10 October 2012.
Sara Kim, PhD, Director, Associate Professor Instructional Design and Technology Unit, UCLA David Geffen School of Medicine Katherine Wigan, BS, MBA, Senior.
CERCA: Healthcare Working Group Fall Meeting October 12, 2011.
INTERNET2 COLLABORATIVE INNOVATION PROGRAM DEVELOPMENT Florence D. Hudson Senior Vice President and Chief Innovation.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Demystifying the Business Analysis Body of Knowledge Central Iowa IIBA Chapter December 7, 2005.
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
Certification and Accreditation CS Phase-1: Definition Atif Sultanuddin Raja Chawat Raja Chawat.
What is a Business Analyst? A Business Analyst is someone who works as a liaison among stakeholders in order to elicit, analyze, communicate and validate.
Europe's work in progress: quality of mHealth Pēteris Zilgalvis, J.D., Head of Unit, Health and Well-Being, DG CONNECT Voka Health Community 29 September.
Project Kick-off Meeting Presented By: > > > > Office of the Chief Information Officer.
Strategies for Knowledge Management Success SCP Best Practices Showcase March 18, 2004.
Business Analysis. Business Analysis Concepts Enterprise Analysis ► Identify business opportunities ► Understand the business strategy ► Identify Business.
MDIC 1 George Serafin Deloitte & Touche LLP MDIC Open Forum Quality System Maturity Model Update.
1 Garth Conrad VP Quality Medtronic Advanced Analytics to Improve Medical Device Quality.
MDIC/Xavier University Device Product Quality Metrics October 8,
Competency-Development Project 08-October MDIC 2 What is the Competency-Development Project? ‏ Purpose: The purpose of this project is to improve.
Investigational Devices and Humanitarian Use Devices June 2007.
1 Suzanne Fiorino, MDIC CfQ Program Manager MDIC Case for Quality Open Forum October 8, 2015.
Evaluate Phase Pertemuan Matakuliah: A0774/Information Technology Capital Budgeting Tahun: 2009.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Project Management Training
SPC Advisory Committee Training - TAC Fall 2015 Institutional Research President’s Office 1 Abridged from the SPC Advisory Committee Training on October.
SPC Advisory Committee Training Fall 2015 Institutional Research President’s Office SPC 10/9/20151.
CT TEFT 1 November 5, Agenda Introduction Goal of Pilot Tier Piloting Activity to Pilot Role of Connecticut in the pilot Standards and Technologies.
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
Competency-Development Project 08-December MDIC 2 What is the Competency-Development Project? ‏ Purpose: The purpose of this project is to improve.
MDIC/Xavier University Device Product Quality Metrics December 8, 2015.
CDRH Advisory Committee Meeting: Orthopedic and Rehabilitation Devices Panel November 20, 2002 INDEPENDENCE™ iBOT™ 3000 Mobility System Independence Technology.
24 October 2006 Industry Dialogue on xoserve services – Work Plan.
Transmission Advisory Group NCTPC Process Update Rich Wodyka September 7, 2006.
MyFloridaMarketPlace Quality Improvement Plan. Page 2 MFMP Quality Improvement Plan  The MFMP team has developed a quality improvement plan that addresses.
© 2014 By Katherine Downing, MA, RHIA, CHPS, PMP.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Program Performance Criteria.
#SVscot Developing a Framework for Hearing the Voice of Citizens in Health and Social Care.
Conferenceboard.ca Aligning, Foreseeing, and Optimizing HTA in Canada 2016 CADTH Symposium April 12, 2016 Dr. Gabriela Prada Director, Health Innovation.
Stages of Research and Development
November 9, 2015 February 20, 2017 Using real world evidence – industry perspective Pma indication expansion Melissa hasenbank, phd Sr. Clinical Research.
RAC Regulatory Affairs Certification
Jim Bland Executive Director, CRIX International
U.S. FDA Center for Devices and Radiological Health Update
Jeff Shuren, MD, JD Center for Devices and Radiological Health U. S
TechStambha PMP Certification Training
FDA Guidance for Industry and FDA Staff Summary of Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”) Effective: December.
Description of Revision
Strategic & Operational Planning:
Department of Licensing HP 3000 Replatforming Project Closeout Report
Introduction to TransCelerate
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Towards International Harmonized Nomenclature for Medical Devices
IESBA CAG Meeting New York, USA March 4, 2019
{Project Name} Organizational Chart, Roles and Responsibilities
Presentation transcript:

Advanced Analytics for Medical Device Quality December Case for Quality Forum Dec 8, 2015 Ann Ferriter

Charter Problem Description Objective Project Scope Included Excluded Stakeholders require accurate and complete data to make educated decisions to improve patient access to high quality devices. Three significant challenges to data on medical device quality: Lack of unbiased, relevant and available data No consistently applied performance measures and analytical methods No secure process or operating model to enable and encourage individual companies to be fully transparent about product quality. Objective To provide information and analysis techniques to stakeholders regarding medical device quality and subsequent patient value Project Scope Included Excluded Phase 1 Use case definition: Value Analysis Team and decisions regarding purchasing devices with defined device areas Use case development: conversion of data to information, create a set to validate Use case pilot and operating model options: identify benefits, identify what it would take to make into a working model Not all stakeholders will be included in Phase 1 - Phase I will focus on Value Analysis teams. Future expansions could consider Group Purchasing Organizations, Payers, Healthcare professionals, patients, industry, etc. .

Steering Committee Sponsor Team members Joanna Engelke Boston Scientific joanna.engelke@bsci.com Garth Conrad Medtronic - Spinal garth.conrad@medtronic.com Ann Ferriter FDA Ann.Ferriter@fda.hhs.gov Mike Schiller AHRMM mschiller@aha.com Steering Committee Sponsor Project Leader Project Leader Jacqueline Berretta J&J - ASP jberret@ITS.JNJ.com Jeff Kaser J&J - Depuy jkaser@ITS.JNJ.com Nathan Soderborg Exponent nsoderborg@exponent.com Melissa Lalomia Stryker melissa.lalomia@stryker.com Daniel Matlis Axendia dmatlis@axendia.com George Serafin Deloitte & Touche LLP gserafin@deloitte.com Rahmat Muhammad Deloitte & Touche LLP rmuhammad@deloitte.com Danqing Yu Deloitte & Touche LLP danqyu@deloitte.com Rachael Marshall Deloitte & Touche LLP ramarshall@deloitte.com Project Manager

Voice of Customer

VoC: factors that impact purchase decisions Participants identified three factors that impact purchase decisions: Quality categories: Safety Effectiveness Reliability Patient Experience Usability Clinician satisfaction Availability Compatibility Finance Quality Patient and clinician satisfaction Participants confirmed that the proposed quality categories are relevant to the purchase decision but indicated that reliable information is scarce.

VoC: willingness to participate in a pilot Orlando Health Providence Health & Services VA Baptist Health Kettering Health Network UAB Hospital All participants are willing to participate in a pilot. However, they require clarity on scope and requirements for them to share information.

Quality Categories

Proposed quality categories: Safety and Effectiveness Quality category Proposed definition Safety Medical devices should be designed and manufactured in such a way that, when used under the conditions and for the purposes intended and, where applicable, by virtue of the technical knowledge, experience, education or training of intended users, they will not compromise the clinical condition or the safety of patients, or the safety and health of users or, where applicable, other persons, provided that any risks which may be associated with their use constitute acceptable risks when weighed against the benefits to the patient and are compatible with a high level of protection of health and safety. Essential Principles of Safety & Performance of Medical Devices GHTF (SG1-N020R5) June 30, 1999 Effectiveness A device is clinically effective when it produces the effect intended by the manufacturer relative to the medical conditions … Effectiveness can be thought of as efficacy in the real world clinical environment. MEDICAL DEVICE REGULATIONS, Global overview and guiding principles

Additional proposed quality categories Quality category Proposed definition Reliability Device will perform satisfactorily for a specified period of time under stated use conditions. Patient Satisfaction Patient’s perception that a device met or exceeded expectations of usability and outcome. Usability A characteristics of the device or device user interface that facilitates use and thereby establishes effectiveness, efficiency and user satisfaction in the intended use environment. Availability Device is available to fill first request orders. Compatibility If the device is intended for use in combination with other devices or equipment, the whole combination, including the connection system should be safe and should not impair the specified performance of the devices. Any restrictions on use applying to such combinations should be indicated on the label and/or in the instructions for use. Essential Principles of Safety and Performance of Medical Devices, FDA, GHTF/SG1/N41R9:2005 Note: These definitions are appropriate for the Analytics pilot. The definitions may evolve as a wider variety of devices bring added complexity to the terms.

Sources of information about product quality Pooled data from Value Analysis Teams Registry data Clinical trial data FDA Adverse Events (MAUDE, SUS) FDA R&L, 510(k), PMA MedSun Reliability information Maintenance Logs Hospital Risk Management Patient survey information Clinician input on usability Product specifications and reference to Standards

Pilot Plan

Activities to pilot launch Define hypothesis Define quality categories, metrics and data sources Identify participants (Value Analysis Committees) Identify device types for the pilot Develop dashboards Draft communications to pilot participants, including roles and responsibilities Share dashboards with VACs, update based on feedback Analyze VAC use of information Finalize recommendations for analytics in medical device quality (include recommendations for operating model)

Phase 1: Value Analysis Committee Purchasing Hypothesis If VACs had access to the following information about implanted cardiac and orthopedic device performance: Safety Effectiveness Reliability Patient experience Usability Availability Compatibility and they applied predictive analytics to this information, then they would make better informed purchasing decisions to improve patient access to high quality medical devices.

Device type for the pilot Low interest Medium High interest Commodities (ventilators, infusion pumps), Neuroembolization Cardiac catheters Implants (stents, surgical mesh, pacemakers, defibrillators, large joints, spine) Device areas selected for pilot: Knees and Defibrillators

Key Activities and Dates Pilot Timeline Key Activities and Dates Pilot Activities Dates Develop dashboards 20 Nov to 8 Jan 16 Identify data to be pooled from hospitals 14 Dec to 4 Jan 16 Draft pilot participant roles and pilot expectations Share dashboards with Value Analysis Teams and request participation Device areas: Knees and Defibrillators Quality criteria: Safety, Effectiveness, Usability, Availability, Reliability and Compatibility 11 Jan 16 Identify pilot participants Goal 3 Value Analysis Teams 15 Jan 16 Pilot use of quality information with Value Analysis Teams Gather feedback on 6 purchasing decisions 30 Jan 16 to 30 Mar 16 Analyze results and draft recommendation 31 Apr 16 Pilot Goal: Determine whether device quality information can be used effectively in Value Analysis Team purchasing decisions

Illustrative Example Device 1 Device 2 Device 3 Device 4

Status and Timeline

MDIC Analytics Project status: 8 Dec 2015 Key Deliverables / Milestones Milestones / Deliverable Dates Percent Complete Status Prepare and approve charter 25 Sep 15 100% Form hypothesis 09 Oct 15 100 % Interview Value Analysis teams 10 Nov to 20 Nov 15 Identify quality characteristics, metrics, data sources Select device areas Develop and share pilot proposal at CfQ forum 7 Dec 15 Develop dashboards 20 Nov to 8 Jan 16 0% Identify pilot participants 15 Jan 16 Pilot prep Pilot use of Quality information with Value Analysis Teams 30 Jan 16 to 30 Mar 16 0 % Analyze results and draft recommendation 31 Apr 16 Results / Accomplishments Interviewed Value Analysis Teams including: UAB Hospital, Birmingham AL, Baptist Health, Little Rock, AR, Kettering Health Network, Miamisburg, OH, Orlando Health, Orlando, FL, VA NCPS, Ann Arbor, MI, Providence Health & Services Seattle, WA Identified sources of information on Safety, Effectiveness, Usability, Availability, Reliability and Compatibility Selected knees and defibrillators as pilot device areas. C C C C Upcoming Activities Activity Target Date Create dashboards with Safety, Effectiveness, Usability, Availability, Reliability and Compatibility information on knees and defibrillators 8 Jan 16 Draft detailed pilot plan 15 Jan 16 Draft advanced analytics agenda for CfQ forum December 8th in Washington, DC 7 Dec 15 C C Y G G Issues/Risks Mitigation Aggressive timeline Need resources to develop dashboards Requesting resources Request to pool data from Value Analysis teams G G G Y R = On Time = At Risk = Late C = Complete

Project timeline and milestones September 2015 October November December January 2016 February March 2016 April Timeline Use Case Definition Present project plan and initial voice of customer data at CfQ Forum Prepare and Approve Charter Form hypothesis (what are we trying to get out of the data?) Gather additional information to refine hypothesis, quality characteristics, and feasibility of obtaining Finalize quality characteristics, metrics and data sources and propose pilot plan Pilot Development Develop mock dashboards for agreed-upon quality characteristics Present pilot plan at CfQ Forum Identify three (3) pilot participants Conduct Pilot Pilot prep Pilot kickoff Develop recommendations for operating model

Questions?